Literature DB >> 6606518

Serum complement proteins in IgA nephropathy.

B A Julian, R J Wyatt, R G McMorrow, J H Galla.   

Abstract

Immunohistologic studies in IgA nephropathy which have suggested activation of the alternative complement pathway prompted us to study serum complement components and control proteins in 28 patients with IgA nephropathy. Thirteen patients, 12 of whom were men, had or developed chronic renal failure (CRF) during 34 +/- 5 months of follow-up. These patients were more hypertensive and had heavier proteinuria than those with stable renal function. Their serum IgA concentrations were not different from patients with normal renal function. The prevalence of HLA antigens was similar to that for the reference population and BW35 was not associated with CRF. Serum C3, B, H and I concentrations in patients with stable normal renal function were higher than they were in patients with CRF. Four patients studied--two with normal renal function and two with CRF--had partial familial deficiencies of single complement proteins. Our data suggest that high serum levels of C3, B, H and I may be associated with stable normal glomerular filtration rate and that complement deficiencies are not infrequent in IgA nephropathy. How these findings relate to the pathogenesis and progression of IgA nephropathy requires further study. We also conclude that higher serum IgA concentrations and the presence of BW35 are not necessarily associated with progressive renal insufficiency in IgA nephropathy.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6606518

Source DB:  PubMed          Journal:  Clin Nephrol        ISSN: 0301-0430            Impact factor:   0.975


  9 in total

1.  Can one predict the prognosis in patients with IgA nephropathy from the analysis of serum complement?

Authors:  R J Wyatt
Journal:  Pediatr Nephrol       Date:  1989-10       Impact factor: 3.714

Review 2.  Biomarkers in IgA nephropathy: relationship to pathogenetic hits.

Authors:  Margaret Colleen Hastings; Zina Moldoveanu; Hitoshi Suzuki; Francois Berthoux; Bruce A Julian; John T Sanders; Matthew B Renfrow; Jan Novak; Robert J Wyatt
Journal:  Expert Opin Med Diagn       Date:  2013-11

3.  Lack of complement activation by human IgA immune complexes.

Authors:  H Imai; A Chen; R J Wyatt; A Rifai
Journal:  Clin Exp Immunol       Date:  1988-09       Impact factor: 4.330

4.  An immunohistological study of IgA nephropathy and a report of its incidence in Ireland.

Authors:  O Browne; G D Doyle; E Campbell
Journal:  Ir J Med Sci       Date:  1985-12       Impact factor: 1.568

5.  IgA nephropathy in adults: immunohistologic findings and clinical course.

Authors:  S K Parai; T Ghose
Journal:  Can Med Assoc J       Date:  1985-06-15       Impact factor: 8.262

6.  Urinary IgA in IgA nephropathy and Henoch-Schoenlein purpura.

Authors:  J H Galla; M F Spotswood; L A Harrison; J Mestecky
Journal:  J Clin Immunol       Date:  1985-09       Impact factor: 8.317

7.  In vivo activation of complement by IgA in a rat model.

Authors:  R K Stad; W M Bogers; M E Thoomes-van der Sluys; L A Van Es; M R Daha
Journal:  Clin Exp Immunol       Date:  1992-01       Impact factor: 4.330

8.  C4 isotype deficiency in IgA nephropathy.

Authors:  T R Welch; A Berry; L S Beischel
Journal:  Pediatr Nephrol       Date:  1987-04       Impact factor: 3.714

9.  Excretion of complement proteins and its activation marker C5b-9 in IgA nephropathy in relation to renal function.

Authors:  Kisara Onda; Isao Ohsawa; Hiroyuki Ohi; Mariko Tamano; Satoshi Mano; Michiro Wakabayashi; Akie Toki; Satoshi Horikoshi; Teizo Fujita; Yasuhiko Tomino
Journal:  BMC Nephrol       Date:  2011-11-23       Impact factor: 2.388

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.